Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The recent emergence of highly pathogenic avian influenza virus (HPAI) strains in poultry and their subsequent transmission to humans in Southeast Asia have raised concerns about the potential pandemic spread of lethal disease. In this paper we describe the development and testing of an adenovirus-based influenza A virus vaccine directed against the hemagglutinin (HA) protein of the A/Vietnam/1203/2004 (H5N1) (VN/1203/04) strain isolated during the lethal human outbreak in Vietnam from 2003 to 2005. We expressed different portions of HA from a recombinant replication-incompetent adenoviral vector, achieving vaccine production within 36 days of acquiring the virus sequence. BALB/c mice were immunized with a prime-boost vaccine and exposed to a lethal intranasal dose of VN/1203/04 H5N1 virus 70 days later. Vaccination induced both HA-specific antibodies and cellular immunity likely to provide heterotypic immunity. Mice vaccinated with full-length HA were fully protected from challenge with VN/1203/04. We next evaluated the efficacy of adenovirus-based vaccination in domestic chickens, given the critical role of fowl species in the spread of HPAI worldwide. A single subcutaneous immunization completely protected chickens from an intranasal challenge 21 days later with VN/1203/04, which proved lethal to all control-vaccinated chickens within 2 days. These data indicate that the rapid production and subsequent administration of recombinant adenovirus-based vaccines to both birds and high-risk individuals in the face of an outbreak may serve to control the pandemic spread of lethal avian influenza.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia
Li, K. S., Guan, Y., Wang, J., Smith, G. J. D., Xu, K. M., Duan, L., Rahardjo, A. P., Puthavathana, P., Buranathai, C., Nguyen, T. D., et al. (2004) · Nature · doi:10.1038/nature02746 · Cited by 1,343
Shiver, J. W., Fu, T.-M., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z.-Q., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,176
Yuen, K., Chan, P., Peiris, M., Tsang, D., Que, T., Shortridge, K., Cheung, P., To, W., Ho, E., Sung, R., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01182-9 · Cited by 1,052
Barouch, D. H., Santra, S., Schmitz, J. E., Kuroda, M. J., Fu, T.-M., Wagner, W., Bilska, M., Craiu, A., Zheng, X. X., Krivulka, G. R., et al. (2000) · Science · doi:10.1126/science.290.5491.486 · Cited by 881
Construction of adenovirus vectors through Cre-lox recombination
Hardy, S., Kitamura, M., Harris-Stansil, T., Dai, Y., & Phipps, M. L. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.1842-1849.1997 · Cited by 789
Nicholson, K. G., Wood, J. M., & Zambon, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14854-4 · Cited by 691
Development of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z.-Y., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 663
The evolution of H5N1 influenza viruses in ducks in southern China
Chen, H., Deng, G., Li, Z., Tian, G., Li, Y., Jiao, P., Zhang, L., Liu, Z., Webster, R. G., & Yu, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403212101 · Cited by 536
Lu, X., Tumpey, T. M., Morken, T., Zaki, S. R., Cox, N. J., & Katz, J. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5903-5911.1999 · Cited by 371
Self-citationProtection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein
Epstein, S. L., Kong, W.-P., Misplon, J. A., Lo, C.-Y., Tumpey, T. M., Xu, L., & Nabel, G. J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.047 · Cited by 285
Shiver, J. W., & Emini, E. A. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104344 · Cited by 280
Replication-Defective Vector Based on a Chimpanzee Adenovirus
Farina, S. F., Gao, G.-P., Xiang, Z. Q., Rux, J. J., Burnett, R. M., Alvira, M. R., Marsh, J., Ertl, H. C. J., & Wilson, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11603-11613.2001 · Cited by 272
Nwanegbo, E., Vardas, E., Gao, W., Whittle, H., Sun, H., Rowe, D., Robbins, P. D., & Gambotto, A. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.2.351-357.2004 · Cited by 266
Self-citationSubbarao, K., Chen, H., Swayne, D., Mingay, L., Fodor, E., Brownlee, G., Xu, X., Lu, X., Katz, J., Cox, N., et al. (2003) · Virology · doi:10.1006/viro.2002.1742 · Cited by 246
Self-citationAbe, T., Takahashi, H., Hamazaki, H., Miyano-Kurosaki, N., Matsuura, Y., & Takaku, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1133 · Cited by 229
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans
Van Kampen, K. R., Shi, Z., Gao, P., Zhang, J., Foster, K. W., Chen, D.-T., Marks, D., Elmets, C. A., & Tang, D.-C. C. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.07.043 · Cited by 220
Barouch, D. H., Santra, S., Kuroda, M. J., Schmitz, J. E., Plishka, R., Buckler-White, A., Gaitan, A. E., Zin, R., Nam, J.-H., Wyatt, L. S., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.11.5151-5158.2001 · Cited by 189
Stephenson, I., Wood, J. M., Nicholson, K. G., Charlett, A., & Zambon, M. C. (2004) · Virus Research · doi:10.1016/j.virusres.2004.02.019 · Cited by 187
Fleeton, M. N., Chen, M., Berglund, P., Rhodes, G., Parker, S. E., Murphy, M., Atkins, G. J., & Liljeström, P. (2001) · The Journal of Infectious Diseases · doi:10.1086/319857 · Cited by 157 · cited 1×
“The ability of DNA-based influenza virus vaccination using adenoviral delivery or other methods (1, 5, 10, 13, 21, 35, 36) to induce a T-cell response able to cross-protect at least partially against heterotypic infection could represent an added value, rendering further investigation in the influenza virus recombinan…”
MethodStrategies for inducing protection against avian influenza A virus subtypes with DNA vaccines
Kodihalli, S., Kobasa, D., & Webster, R. G. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00485-5 · Cited by 123
Wesley, R. D., Tang, M., & Lager, K. M. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.02.040 · Cited by 117
Pinto, A. R., Fitzgerald, J. C., Giles‐Davis, W., Gao, G. P., Wilson, J. M., & Ertl, H. C. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6774 · Cited by 113
UpGene: Application of a Web‐Based DNA Codon Optimization Algorithm
Gao, W., Rzewski, A., Sun, H., Robbins, P. D., & Gambotto, A. A. (2004) · Biotechnology Progress · doi:10.1021/bp0300467 · Cited by 109
Self-citationBender, B. S., Rowe, C. A., Taylor, S. F., Wyatt, L. S., Moss, B., & Small, P. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6418-6424.1996 · Cited by 105
Human adenovirus type 35: nucleotide sequence and vector development
Gao, W., Robbins, P. D., & Gambotto, A. A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302097 · Cited by 80
Self-citationMei, Y.-F., Skog, J., Lindman, K., & Wadell, G. (2003) · Journal of General Virology · doi:10.1099/vir.0.19178-0 · Cited by 57
Brown, K. E., Gao, W., Alber, S. M., Trichel, A. M., Murphey‐Corb, M., Watkins, S. C., Gambotto, A. A., & Barratt‐Boyes, S. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6875 · Cited by 51
Self-citationChen, J.-D., Yang, Q., Yang, A., Marasco, W. A., & Chen, S. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.13-1515 · Cited by 33
Cellular immune responses to influenza.
Moss, P. A. H. (2003) · PubMed · Cited by 21
Cited by
Emergence and pandemic potential of swine-origin H1N1 influenza virus
Neumann, G., Noda, T., & Kawaoka, Y. (2009) · Nature · doi:10.1038/nature08157 · Cited by 1,561
Kim, E., Erdos, G., Huang, S., Kenniston, T. W., Balmert, S. C., Carey, C. D., Raj, V. S., Epperly, M. W., Klimstra, W. B., Haagmans, B. L., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102743 · Cited by 404
Self-citationThe challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
Karlsson Hedestam, G. B., Fouchier, R. A. M., Phogat, S., Burton, D. R., Sodroski, J., & Wyatt, R. T. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1819 · Cited by 339
Human infection with highly pathogenic H5N1 influenza virus
Gambotto, A., Barratt-Boyes, S. M., de Jong, M. D., Neumann, G., & Kawaoka, Y. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60627-3 · Cited by 316
Self-citationSandbulte, M. R., Jimenez, G. S., Boon, A. C. M., Smith, L. R., Treanor, J. J., & Webby, R. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040059 · Cited by 295
Metadata
- Authors
- Gao, W., Soloff, A. C., Lu, X., Montecalvo, A., Nguyen, D. C., Matsuoka, Y., Robbins, P. D., Swayne, D. E., Donis, R. O., Katz, J. M., Barratt-Boyes, S. M., & Gambotto, A.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-02-15
- Volume
- 80
- Issue
- 4
- Pages
- 1959-1964
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2101954404
- Cited by
- 270
- References
- 29
- FWCI
- 23.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.